8-KItem 8.01 · Other EventsItem 9.01 · Financial Statements

Zimmer Biomet recasts 2025 segment disclosures after reporting changes

Filed with the SEC on August 5, 2026 · Summarized by InvestorsBot

On August 5, 2026, Zimmer Biomet recast portions of its 2025 Form 10-K to reflect operating-segment changes made in the quarter ended March 31, 2026. Foot and Ankle results from EMEA and Asia Pacific, along with certain centralized R&D and global marketing costs, are now reported within the Americas segment; the company said the filing does not amend or restate its 2025 financial results or update other information.

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from ZIMMER BIOMET HOLDINGS, INC.

Zimmer Biomet promotes three leaders in Americas commercial restructuring

8-K · September 8, 2026

Zimmer Biomet Restructures Americas Leadership as Kevin Thornal Departs

8-K · September 8, 2026

Zimmer Biomet raises 2026 guidance after second-quarter sales growth

8-K · August 5, 2026

ZIMMER BIOMET ($ZBH) filed Form 8‑K (Item 9.01) on Feb 10, 2026 — exhibits: Press release dated Feb 10,…

8-K · February 10, 2026

Zimmer Biomet ($ZBH) on Feb 10, 2026 issued a press release with financial results for the quarter and…

8-K · February 10, 2026

Zimmer Biomet ($ZBH) filed an 8-K (Item 9.01) on Jan 12, 2026 furnishing Exhibit 104 — Cover Page…

8-K · January 12, 2026